Effect of Oral Vasopressors Used for Liberation from Intravenous Vasopressors in Intensive Care Unit Patients Recovering from Spinal Shock: A Randomized Controlled Trial
Table 2
Comparison between the studied groups regarding hemodynamic parameters and laboratory findings (n = 90).
Control
Minirin
Midodrine
value
Mean ± SD
Mean ± SD
Mean ± SD
Temperature
1st day of the study
37.23 ± 0.39
37.2 ± 0.4
37.2 ± 0.62
0.953
Midperiod of the study
37.31 ± 0.35
37.34 ± 0.5
37.11 ± 0.39
0.068
Last day of the study
37.17 ± 0.25
37.14 ± 0.27
37.23 ± 0.4
0.541
Heart rate (HR)
1st day of the study
120.43 ± 14.64
120.53 ± 11.91
117.5 ± 14.28
0.622
Midperiod of the study
97.1 ± 16.65
102.8 ± 20.77
103.77 ± 16.65
0.311
Last day of the study
96.73 ± 18.75
91.83 ± 12.71
79 ± 16.9
<0.001
Mean arterial pressure (MAP)
1st day of the study
62.87 ± 19.21
65.83 ± 20.29
52.37 ± 11.77
0.010
Midperiod of the study
83.8 ± 14.64
83.9 ± 11.75
77.17 ± 16.63
0.125
Last day of the study
82.57 ± 13.42
82.57 ± 11.94
77.23 ± 15.83
0.231
Respiratory rate (RR)
1st day of the study
25.33 ± 6.74
23.6 ± 6.93
20.27 ± 5.6
0.011
Midperiod of the study
18.83 ± 4.19
17.53 ± 3.05
17.13 ± 3.27
0.157
Last day of the study
15.7 ± 3.21
15.57 ± 3.11
16 ± 3.13
0.862
Serum creatinine
1st day of the study
90.35 ± 52.22
99.71 ± 39.97
63.87 ± 34.43
0.005
Last day of the study
123.11 ± 112.2
101.95 ± 41.18
92.12 ± 54.76
0.276
Arterial PH
1st day of the study
7.41 ± 0.09
7.39 ± 0.08
7.41 ± 0.09
0.696
Midperiod of the study
7.42 ± 0.08
7.39 ± 0.08
7.42 ± 0.08
0.268
Last day of the study
7.41 ± 0.07
7.39 ± 0.07
7.41 ± 0.07
0.590
Serum HCO3
1st day of the study
19.91 ± 5.58
20.72 ± 7.22
19.91 ± 5.58
0.842
Midperiod of the study
21.99 ± 3.76
22.06 ± 8.06
21.99 ± 3.76
0.999
Last day of the study
23.14 ± 3.72
23.01 ± 7.05
22.77 ± 3.82
0.959
PO2
1st day of the study
103.37 ± 45.09
102.52 ± 39.24
103.37 ± 45.09
0.996
Midperiod of the study
104.07 ± 30.33
89.53 ± 28.56
104.07 ± 30.33
0.098
Last day of the study
82.49 ± 18.57
83.57 ± 23.24
88.32 ± 25.51
0.582
PCO2
1st day of the study
32.04 ± 9.21
33.5 ± 14.52
32.04 ± 9.21
0.846
Midperiod of the study
30.65 ± 6.6
32.33 ± 14.75
30.65 ± 6.6
0.758
Last day of the study
33.19 ± 4.52
32.87 ± 11.52
31.91 ± 5.3
0.803
One-way ANOVA tests quantitative data between the three groups or more. Significant level at value < 0.05; significant level at value < 0.01.
